Brown Brothers Harriman & Co’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$641K Buy
9,172
+3,278
+56% +$229K ﹤0.01% 412
2025
Q1
$433K Sell
5,894
-848
-13% -$62.3K ﹤0.01% 419
2024
Q4
$442K Buy
6,742
+236
+4% +$15.5K ﹤0.01% 428
2024
Q3
$507K Buy
6,506
+444
+7% +$34.6K ﹤0.01% 400
2024
Q2
$473K Buy
6,062
+216
+4% +$16.8K ﹤0.01% 387
2024
Q1
$396K Sell
5,846
-39
-0.7% -$2.64K ﹤0.01% 396
2023
Q4
$396K Sell
5,885
-662
-10% -$44.6K ﹤0.01% 384
2023
Q3
$443K Buy
6,547
+513
+9% +$34.7K ﹤0.01% 359
2023
Q2
$432K Sell
6,034
-539
-8% -$38.6K ﹤0.01% 346
2023
Q1
$456K Buy
6,573
+756
+13% +$52.5K ﹤0.01% 352
2022
Q4
$394K Sell
5,817
-543
-9% -$36.8K ﹤0.01% 350
2022
Q3
$349K Buy
6,360
+1,166
+22% +$64K ﹤0.01% 363
2022
Q2
$343K Buy
5,194
+618
+14% +$40.8K ﹤0.01% 371
2022
Q1
$304K Buy
4,576
+3,959
+642% +$263K ﹤0.01% 422
2021
Q4
$36 Hold
617
﹤0.01% 754
2021
Q3
$37 Buy
617
+435
+239% +$26 ﹤0.01% 725
2021
Q2
$11 Hold
182
﹤0.01% 880
2021
Q1
$9 Sell
182
-200
-52% -$10 ﹤0.01% 875
2020
Q4
$19K Buy
382
+256
+203% +$12.7K ﹤0.01% 785
2020
Q3
$7K Hold
126
﹤0.01% 789
2020
Q2
$7K Sell
126
-63
-33% -$3.5K ﹤0.01% 778
2020
Q1
$8K Buy
189
+63
+50% +$2.67K ﹤0.01% 717
2019
Q4
$6K Sell
126
-1,186
-90% -$56.5K ﹤0.01% 955
2019
Q3
$58K Hold
1,312
﹤0.01% 619
2019
Q2
$54K Buy
1,312
+1,186
+941% +$48.8K ﹤0.01% 575
2019
Q1
$5K Sell
126
-111
-47% -$4.41K ﹤0.01% 896
2018
Q4
$9K Hold
237
﹤0.01% 696
2018
Q3
$9K Buy
+237
New +$9K ﹤0.01% 685
2017
Q2
Sell
-351
Closed -$11K 750
2017
Q1
$11K Buy
+351
New +$11K ﹤0.01% 644
2015
Q4
Sell
-1,308
Closed -$42K 740
2015
Q3
$42K Buy
+1,308
New +$42K ﹤0.01% 511
2015
Q1
Sell
-3,700
Closed -$130K 761
2014
Q4
$130K Hold
3,700
﹤0.01% 408
2014
Q3
$132K Sell
3,700
-100
-3% -$3.57K ﹤0.01% 403
2014
Q2
$141K Buy
+3,800
New +$141K ﹤0.01% 396
2013
Q3
Sell
-34
Closed -$1K 704
2013
Q2
$1K Buy
+34
New +$1K ﹤0.01% 706